PARK7 and cancer: Proteomic studies and pathway analysis revealed that PARK7 is highly expressed in DHA-resistant cell lines, and the upregulation of PARK7 protects cancer cells from DHA-induced ROS and apoptosis by increasing the stability of Nrf2.